Welcome

If you have commercial insurance and wish to use Adbry® (tralokinumab-ldrm) injection distributed by Leo Pharma, Inc., you will likely have to enroll in the Adbry® Copay Card because of the product's exorbitant cost. I created this site to share information about the unwarranted charges and incredible frustration that I experienced as a commercially insured patient using the Adbry® Copay Card. Hopefully this information will help others avoid what happened to me.

Who am I?

My name is Shawn Harbaugh, and I am a data scientist who lives and works in Central Pennsylvania, USA. Eczema became a serious problem for me in the year 2020. I tried multiple prescription topicals and they provided only moderate relief. Next was DUPIXENT®, but I had a tough time getting the large needle through my skin, and when the penetration was successful, the medication squirted out of the injection site during withdrawal. Unlike DUPIXENT's 1 large vial and needle, Adbry uses 2 smaller ones, and I was excited to get started. I used Adbry for over a year, until the chaos began with their copay program, and so begins my story.

Chronological Timeline of Events

September 10, 2024 — Adbry Copay Program rejected payment to Accredo Specialty Pharmacy for $1,182.35. Accredo shipped the product without notifying me about the payment failure and later sent a statement showing a patient balance due of $1,182.35. I assumed this was a mistake because I was well under the copay program annual maximum.

October 2, 2024 — Adbry Copay Program again rejected payment to Accredo for $1,182.35. Accredo again shipped the product without notifying me and later sent a statement showing a patient balance of $2,364.70. I immediately suspended any further Adbry shipments.

November 14, 2024 — Called an Adbry Advocate and learned that Accredo may have been billing my former DUPIXENT Copay Program. I went into the Accredo site and found ID, Bin, PCN, and Group codes for my old DUPIXENT MyWay® Copay Card. I never entered this information in the first place but was nevertheless able to correct it on the Accredo website.

December 12, 2024 — Received a statement showing an Accredo patient balance of $2,364.70. Called Accredo and they said they would rebill Adbry Copay and I should call back in 10 days.

January 17, 2025 — Accredo called me and said that rebilling generated a message stating that I exceeded my annual limit and that I should contact Adbry Copay Support for assistance.

January 20, 2025 — Adbry Copay Support instructed me to call the Accredo billing department and request an override. The Accredo billing department called Adbry Copay and was informed that an override was received for the 9/10/2024 shipment and that it will process in 1 or 2 days. I was told to call Accredo again in 3 days and to ask the rep to follow the notes to override the rejected payment for the 10/2/2024 shipment. I was further informed that Adbry changed the copay program in July 2024, and this was the likely cause of all the billing problems.

January 24, 2025 — Called Accredo and learned that the override for the 9/10/2024 failed because Adbry Copay needs more information: (1) Are you in a maximizer program? (2) Does your insurance company cover 100% of the product cost? I stated that I am not in a maximizer program (confirmed with Highmark) and my insurance does not pay 100% for Adbry. I was told to call Accredo back in a few days.

January 29, 2025 — Spoke to Accredo Copay Support and was told that my request was still in escalation on the Adbry side. Later that day Accredo called me and put an Adbry rep on the line. She (rep) asked (1) Are you in a maximizer program? (2) Does your insurance company cover 100% of the product cost? Once again, I said no to both questions. She said she would resubmit the payment request and that I should call back in 3 days.

February 3, 2025 — Called Accredo Copay Support and was told that the Adbry Copay Program needs more time to evaluate the situation and that I should call back on Friday (February 7).

February 7, 2025 — Called Adbry Copay Support and was told that the payments were rejected because I am in the insurance company’s maximizer program (wrong, wrong, wrong). I was further told that I should call back on Monday (February 10) afternoon and request a resubmission.

February 12, 2025 — Called Adbry Copay Support and was told that the override is still being processed and that I should call back on February 14. At this point I had enough and never called back, which was apparently what they were striving for.

June 23, 2025 — Received a letter from Accredo threatening to submit my outstanding balance to National Recovery Agency for collection.

June 27, 2025 — I paid the $2,364.70 out of pocket.

What Would I do Differently?

Stay away from Adbry! There are plenty of other options in the marketplace. For me, Adbry's performance was unremarkable, especially for what it cost me and my insurance company. Right now I'm achieving reasonable results through a combination of stress reduction and Betamethasone cream, and an antibiotic ointment for skin breaks that refuse to heal.

Here is a blunt summary of my Adbry Copay Card experience: They can stop copay assistance at any time, without warning, for any reason, and you are then responsible for any outstanding pharmacy balance. An Adbry Advocate will not help, copay program representatives will send you in circles, and the pharmacy will only come after you for the money, not the copay program. Read the Adbry Copay Card terms and conditions; you are screwed!

I wish you the best in your eczema treatment journey!